Literature DB >> 12902592

Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy.

N R Goldsack1, S Allen, M C I Lipman.   

Abstract

We report a patient who developed adult respiratory distress syndrome (ARDS) secondary to Mycobacterium tuberculosis as an immune reconstitution disease. This complication occurred 14 days after the commencement of highly active antiretroviral therapy (HAART) for advanced HIV infection. The case emphasises that immune reconstitution can be an extremely aggressive complication of HAART.

Entities:  

Mesh:

Year:  2003        PMID: 12902592      PMCID: PMC1744716          DOI: 10.1136/sti.79.4.337

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  27 in total

1.  Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?

Authors:  April C Pettit; Cathy A Jenkins; Samuel E Stinnette; Peter F Rebeiro; Robert B Blackwell; Stephen P Raffanti; Bryan E Shepherd; Timothy R Sterling
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-01       Impact factor: 3.731

2.  Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection.

Authors:  Thanyawee Puthanakit; Peninnah Oberdorfer; Nuthapong Ukarapol; Noppadon Akarathum; Suchart Punjaisee; Thira Sirisanthana; Virat Sirisanthana
Journal:  Pediatr Infect Dis J       Date:  2006-07       Impact factor: 2.129

3.  Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.

Authors:  Stephen D Lawn; Katharina Kranzer; David J Edwards; Matthew McNally; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

Review 4.  Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART.

Authors:  Matthias Stoll; Reinhold E Schmidt
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

5.  Illness of Immune Reconstitution: Recognition and Management.

Authors:  Edward M Gardner; Elizabeth Connick
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

Review 6.  Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.

Authors:  Stephen D Lawn; Graeme Meintjes
Journal:  Expert Rev Anti Infect Ther       Date:  2011-04       Impact factor: 5.091

7.  Characteristics and outcomes of HIV-1-infected patients with acute respiratory distress syndrome.

Authors:  Freny J Nirappil; Ana Maheshwari; Joel Andrews; Greg S Martin; Annette M Esper; Sushma K Cribbs
Journal:  J Crit Care       Date:  2014-10-30       Impact factor: 3.425

Review 8.  [Immune restoration inflammatory syndromes].

Authors:  M Stoll; H Heiken; G M N Behrens; R E Schmidt
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

Review 9.  [Immune reconstitution inflammatory syndrome (IRIS)].

Authors:  A D Wagner
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

10.  Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.

Authors:  Stephen D Lawn; Landon Myer; David Edwards; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.